Artrya (ASX:AYA): Downgrade valuation, but market overraction represents buying opportunity
The market responded negatively to Artrya’s 4Q26 cash flows today, closing down -16%. While there was some frustration in the delay in realising...
154 Views
Artray (ASX:AYA): Positive customer feedback with scan volumes growing 200%/mth; SAPPHIRE study to kick off in July; Appoints former Pro Medicus CFO as new CFO
Tanner has nice things to say Three visiting senior Tanner Health executives joined Artrya's 3Q26 investor call from Melbourne, giving investors a...
123 Views